| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | WO2002030406A3 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 02/12/2004 | US20040030380 Drug-delivery endovascular stent and method for treating restenosis |
| 02/12/2004 | US20040030379 Energetically-controlled delivery of biologically active material from an implanted medical device |
| 02/12/2004 | US20040030248 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 02/12/2004 | US20040030190 Psychological disorders; antidepressants; chlorination using hydrogen chloride |
| 02/12/2004 | US20040030188 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 02/12/2004 | US20040030165 14 Beta, 16, 17-methylene steroids as novel androgens |
| 02/12/2004 | US20040030164 Process for the preparation of taxan derivatives |
| 02/12/2004 | US20040030156 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 02/12/2004 | US20040030151 Stable amorphous celecoxib composite and process therefor |
| 02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
| 02/12/2004 | US20040030140 Process for preparing pesticidal intermediates |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 02/12/2004 | US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient |
| 02/12/2004 | US20040030121 Crystalline glucosamine sulfate metal salts and processes for preparing the same |
| 02/12/2004 | US20040030118 Methods for regulating hematopoiesis using CpG-oligonucleotides |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030111 Used in directing the misfolding of functional RNA molecules that are characterized by secondary and/or tertiary folding to achieve an active conformation, whereby the misfolding modifies the activity of the RNA molecules |
| 02/12/2004 | US20040030033 New film coating |
| 02/12/2004 | US20040029993 E-ptfe foil impregnated with an encapsulated bioative substance |
| 02/12/2004 | US20040029975 Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds |
| 02/12/2004 | US20040029974 Using undecanone or tridecanone |
| 02/12/2004 | US20040029973 Bupropion to treat viral diseases |
| 02/12/2004 | US20040029972 Synergistic mixtuyre of antidepressant and serotonine receptor antagonist; psychological disorders; sexual disorders |
| 02/12/2004 | US20040029970 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 02/12/2004 | US20040029969 Use of creatine or creatine derivatives in cosmetic or dematological preparations |
| 02/12/2004 | US20040029968 Reducing blood glucose concentration; antidiabetic agents; hydrophilic drug with protective coating |
| 02/12/2004 | US20040029967 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 02/12/2004 | US20040029965 Formulations for reducing or eliminating toxicity of enviromental hormones containing ursodeoxycholic acid |
| 02/12/2004 | US20040029964 Calcium formate for use as a dietary supplement |
| 02/12/2004 | US20040029963 Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 02/12/2004 | US20040029962 HMG-COA reductase inhibitor extended release formulation |
| 02/12/2004 | US20040029960 Prevention, therapy flatworm infections |
| 02/12/2004 | US20040029959 Isosorbide mononitrate compositions and methods of their use |
| 02/12/2004 | US20040029958 Treatment of neurotic disorders |
| 02/12/2004 | US20040029957 Treatment of neurotic disorders |
| 02/12/2004 | US20040029956 Central nervous system disorders; anxiolytic agents; administering escitalopram |
| 02/12/2004 | US20040029955 Composition for use in prevention or treatment of vascular-related diseases |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029953 Use of neuropeptide-y antagonists in treatment of alcoholism |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029949 Antisecretory agents; potassium channel moderators; irritable bowel syndrome |
| 02/12/2004 | US20040029947 R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029945 Method of inhibiting matrix metalloproteinases |
| 02/12/2004 | US20040029943 Antiallergens; antiinflammatory agents; hypotensive agents; central nervous system disorders |
| 02/12/2004 | US20040029942 Compounds and methods for use thereof in the treatment of viral infections |
| 02/12/2004 | US20040029941 Zonisamide use in obesity and eating disorders |
| 02/12/2004 | US20040029940 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/12/2004 | US20040029934 Pharmaceutical emulsion preparation |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029929 Aminoadamantane derivatives as therapeutic agents |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029927 Oral administering of tablet of triprolidine |
| 02/12/2004 | US20040029926 Thiazolidinone nitrate salt |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029924 Administering by mouth; enteric cellulose coated pellets; gastrointestinal disorders |
| 02/12/2004 | US20040029921 Antiinflammatory agents; antipyretics; analgesics |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029918 Bactericides; termite extract |
| 02/12/2004 | US20040029917 Benzosuberonylpiperdine compounds as analgesics |
| 02/12/2004 | US20040029916 Antiarthritic agents; skin disorders; Crohn's disease |
| 02/12/2004 | US20040029915 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 02/12/2004 | US20040029914 Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/12/2004 | US20040029913 Halogenated selective androgen receptor modulators and methods of use thereof |
| 02/12/2004 | US20040029912 Bicyclic derivatives |
| 02/12/2004 | US20040029910 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 02/12/2004 | US20040029909 Heat, sulfurization of the corresponding compound with tetraphosphorus tetrasulfide; Parkinson's disease, sexual disorders |
| 02/12/2004 | US20040029908 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 02/12/2004 | US20040029907 Drug for respiratory system disorders |
| 02/12/2004 | US20040029906 Antiproliferative agents; anticancer agents |
| 02/12/2004 | US20040029905 Using codeine, hydrocodeine, meptazinol, tilidine, propoxyphene |
| 02/12/2004 | US20040029904 Spiro(2H-1benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors |
| 02/12/2004 | US20040029902 2,4-Pyrimidinediamine compounds and their uses |
| 02/12/2004 | US20040029901 Obesity therapy; administering orlistat |
| 02/12/2004 | US20040029900 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 02/12/2004 | US20040029899 Novel compounds |
| 02/12/2004 | US20040029898 Anticancer agents |
| 02/12/2004 | US20040029896 Method for preventing the onset of asthma |
| 02/12/2004 | US20040029895 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 02/12/2004 | US20040029894 Nootropic effect enhancer |
| 02/12/2004 | US20040029893 Method of treatment of non-invasive mucositis |
| 02/12/2004 | US20040029892 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses |
| 02/12/2004 | US20040029891 Use of PDE5 inhibitors in the treatment of polycystic ovary syndrome |
| 02/12/2004 | US20040029890 PH sensitivity; controlling blood concentration; cardiovascular disorders |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders |
| 02/12/2004 | US20040029886 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides |
| 02/12/2004 | US20040029884 Cyclization in presence of Lawesson's reagent |
| 02/12/2004 | US20040029883 Beta-amino acid compounds as integrin antagonists |
| 02/12/2004 | US20040029882 Antimicrobial quinolones, their compositions and uses |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |